170 related articles for article (PubMed ID: 25923888)
1. Discordance between body mass index and anthropometric measurements among HIV-1-infected patients on antiretroviral therapy and with lipoatrophy/lipohypertrophy syndrome.
Soares LR; da Silva DC; Gonsalez CR; Batista FG; Fonseca LA; Duarte AJ; Casseb J
Rev Inst Med Trop Sao Paulo; 2015; 57(2):105-10. PubMed ID: 25923888
[TBL] [Abstract][Full Text] [Related]
2. Self-reported lipodystrophy, nutritional, lipemic profile and its impact on the body image of HIV-1-infected persons, with and without antiretroviral therapy.
Soares LR; Casseb JSDR; Chaba DCDS; Batista LO; Sousa LVA; Fonseca FLA
AIDS Care; 2020 Oct; 32(10):1317-1322. PubMed ID: 31711307
[TBL] [Abstract][Full Text] [Related]
3. [Overweight, obesity and underweight in HIV infected patients].
Kwiatkowska W; Knysz B; Drelichowska-Durawa J; Czarnecki M; Gasiorowski J; Biłyk E; Karczewski M; Witkiewicz W
Przegl Lek; 2013; 70(3):113-7. PubMed ID: 24003663
[TBL] [Abstract][Full Text] [Related]
4. Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4- to 9-year antiretroviral therapy in Senegal: a case-control study.
Mercier S; Gueye NF; Cournil A; Fontbonne A; Copin N; Ndiaye I; Dupuy AM; Cames C; Sow PS; Ndoye I; Delaporte E; Simondon KB
J Acquir Immune Defic Syndr; 2009 Jun; 51(2):224-30. PubMed ID: 19339897
[TBL] [Abstract][Full Text] [Related]
5. Anthropometric definitions for antiretroviral-associated lipodystrophy derived from a longitudinal South African cohort with serial dual-energy X-ray absorptiometry measurements.
Abrahams Z; Maartens G; Levitt N; Dave J
Int J STD AIDS; 2018 Oct; 29(12):1194-1203. PubMed ID: 29945538
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal anthropometric changes in HIV-infected and HIV-uninfected men.
Brown T; Wang Z; Chu H; Palella FJ; Kingsley L; Witt MD; Dobs AS
J Acquir Immune Defic Syndr; 2006 Nov; 43(3):356-62. PubMed ID: 16980910
[TBL] [Abstract][Full Text] [Related]
7. Fat distribution and metabolic abnormalities in HIV-infected patients on first combination antiretroviral therapy including stavudine or zidovudine: role of physical activity as a protective factor.
Domingo P; Sambeat MA; Pérez A; Ordoñez J; Rodriguez J; Vázquez G
Antivir Ther; 2003 Jun; 8(3):223-31. PubMed ID: 12924539
[TBL] [Abstract][Full Text] [Related]
8. Morphological and metabolic components of lipodystrophy in various nevirapine-based highly active antiretroviral therapy (HAART) regimens: a cross-sectional, observational study.
Guaraldi G; Zona S; Orlando G; Carli F; Stentarelli C; Luzi K; Garlassi E; Menozzi M; Bagni P; Adorni F
Clin Drug Investig; 2011 Nov; 31(11):759-67. PubMed ID: 21919542
[TBL] [Abstract][Full Text] [Related]
9. People living with HIV on ART have accurate perception of lipodystrophy signs: a cross-sectional study.
Alencastro PR; Barcellos NT; Wolff FH; Ikeda ML; Schuelter-Trevisol F; Brandão AB; Fuchs SC
BMC Res Notes; 2017 Jan; 10(1):40. PubMed ID: 28086977
[TBL] [Abstract][Full Text] [Related]
10. Detection of lipoatrophy in human immunodeficiency virus-1-infected children treated with highly active antiretroviral therapy.
Hartman K; Verweel G; de Groot R; Hartwig NG
Pediatr Infect Dis J; 2006 May; 25(5):427-31. PubMed ID: 16645507
[TBL] [Abstract][Full Text] [Related]
11. Markers of adiposity in HIV/AIDS patients: Agreement between waist circumference, waist-to-hip ratio, waist-to-height ratio and body mass index.
Dimala CA; Ngu RC; Kadia BM; Tianyi FL; Choukem SP
PLoS One; 2018; 13(3):e0194653. PubMed ID: 29566089
[TBL] [Abstract][Full Text] [Related]
12. Fat Mass Ratio in Brazilian HIV-infected Patients Under Antiretroviral Therapy and Its Relationship With Anthropometric Measurents.
Bicudo Bruno Nogueira A; Abreu JM; Mesquita Villela M; Boracini Sanchez AE; Silva Chaves B; Setubal S; Coca Velarde LG; Cruz Filho RAD; Balarini Lima GA; Soares DV
J Clin Densitom; 2020; 23(4):623-629. PubMed ID: 30545683
[TBL] [Abstract][Full Text] [Related]
13. Lipodystrophic syndromes and hyperlipidemia in a cohort of HIV-1-infected patients receiving triple combination antiretroviral therapy with a protease inhibitor.
Rakotoambinina B; Médioni J; Rabian C; Jubault V; Jais JP; Viard JP
J Acquir Immune Defic Syndr; 2001 Aug; 27(5):443-9. PubMed ID: 11511820
[TBL] [Abstract][Full Text] [Related]
14. HIV lipodystrophy: prevalence, severity and correlates of risk in Australia.
Miller J; Carr A; Emery S; Law M; Mallal S; Baker D; Smith D; Kaldor J; Cooper DA
HIV Med; 2003 Jul; 4(3):293-301. PubMed ID: 12859330
[TBL] [Abstract][Full Text] [Related]
15. Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population.
Hansen AB; Lindegaard B; Obel N; Andersen O; Nielsen H; Gerstoft J
HIV Med; 2006 Jan; 7(1):38-45. PubMed ID: 16313291
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of a bioactive food compound in anthropometric measures of individuals with HIV/AIDS: A nonrandomized trial.
Ferreira RDS; Guimarães RCA; Pontes ERJC; Mendonça LABM; Freitas KC; Hiane PA
PLoS One; 2018; 13(2):e0191259. PubMed ID: 29425211
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of lipodystrophy in HIV-infected children in Tanzania on highly active antiretroviral therapy.
Kinabo GD; Sprengers M; Msuya LJ; Shayo AM; van Asten H; Dolmans WM; van der Ven AJ; Warris A
Pediatr Infect Dis J; 2013 Jan; 32(1):39-44. PubMed ID: 23038217
[TBL] [Abstract][Full Text] [Related]
18. Impact on weight and height with the use of HAART in HIV-infected children.
Guillén S; Ramos JT; Resino R; Bellón JM; Muñoz MA
Pediatr Infect Dis J; 2007 Apr; 26(4):334-8. PubMed ID: 17414398
[TBL] [Abstract][Full Text] [Related]
19. Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART).
Dong KL; Bausserman LL; Flynn MM; Dickinson BP; Flanigan TP; Mileno MD; Tashima KT; Carpenter CC
J Acquir Immune Defic Syndr; 1999 Jun; 21(2):107-13. PubMed ID: 10360801
[TBL] [Abstract][Full Text] [Related]
20. The development of simple anthropometric measures to diagnose antiretroviral therapy-associated lipodystrophy in resource limited settings.
Abrahams Z; Dave JA; Maartens G; Lesosky M; Levitt NS
AIDS Res Ther; 2014; 11():26. PubMed ID: 25143778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
